Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00348933 · ClinicalTrials.gov registry record · NA
Dietary Supplements for the Treatment of Angelman Syndrome
A NA study of Nervous System Diseases and Angelman Syndrome, sponsored by University of California, San Diego.
- Completed
- Registry status
- NA
- Development phase
- 90
- Enrollment target
- 4
- Study locations
NCT00348933 is a NA study of Nervous System Diseases and Angelman Syndrome that has completed, run by University of California, San Diego. The registered enrollment target is 90 participants, below the 320-participant average among 23 other Nervous System Diseases trials with a reported enrollment target (72% lower). The trial reports 4 study locations across 4 states.
The verdict
NCT00348933, a NA study of Nervous System Diseases and Angelman Syndrome, has completed, sponsored by University of California, San Diego.
- COMPLETED
- Registry status
- NA
- Development phase
- 90 participants
- Enrollment target
- 4
- Study locations
Study Summary
Angelman syndrome (AS) is a complex genetic disorder that affects the nervous system. The purpose of this study is to determine the effectiveness of certain dietary supplements in treating the symptoms of AS.
Conditions Studied
Interventions
- DRUG Betaine
- DRUG Creatine
- DRUG Metafolin
- DRUG Vitamin B12
Study Locations (4)
California
- Rady Children's Hospital San Diego - San Diego
Massachusetts
- Children's Hospital Boston - Boston
South Carolina
- Greenwood Genetics Center - Greenwood
Texas
- Baylor College of Medicine - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2006-07 |
| Est. Completion | 2010-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00348933
The ClinicalTrials.gov registry entry for NCT00348933 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 320-participant average among 23 other Nervous System Diseases trials with a reported enrollment target (72% lower). The listed sponsor is University of California, San Diego, which has 775 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Nervous System Diseases appearing as the primary indexed condition, and to 4 interventions - of which Betaine is the first listed.
NCT00348933 reports 4 study locations spanning 4 distinct geographic areas - top geographies include California, Massachusetts, South Carolina.
Frequently Asked Questions
What is clinical trial NCT00348933 about?
NCT00348933 is a clinical study titled "Dietary Supplements for the Treatment of Angelman Syndrome". Angelman syndrome (AS) is a complex genetic disorder that affects the nervous system. The purpose of this study is to determine the effectiveness of certain dietary supplements in treating the symptoms of AS.
What is the current status of trial NCT00348933?
This trial is currently completed. It is a NA study. The enrollment target is 90 participants. The study started on 2006-07. Estimated completion is 2010-02.
What conditions does trial NCT00348933 study?
This clinical trial studies the following conditions: Nervous System Diseases, Angelman Syndrome.
What interventions are being tested in trial NCT00348933?
The interventions under investigation include: Betaine (DRUG), Creatine (DRUG), Metafolin (DRUG), Vitamin B12 (DRUG).
Who is sponsoring clinical trial NCT00348933?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00348933 being conducted?
This trial has 4 study locations across California, Massachusetts, South Carolina, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Nervous System Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Deep Brain Stimulation Motor Ventral Thalamus (VOP/VIM) for Restoration of Speech and Upper-limb Function in People With Subcortical Stroke
RECRUITING · NA
-
The Effect of Transcutaneous Stimulation on Blood Pressure in Spinal Cord Injury (SCI)
RECRUITING · NA
-
Spinal Cord Transcutaneous Stimulation Effect on Blood Pressure in Acute Spinal Cord Injury (SCI)
RECRUITING · NA
-
Neurologic Stem Cell Treatment Study
RECRUITING · NA
-
Brain Connections for Arm Movement After Stroke
RECRUITING · NA
-
Tai Chi Effects on Chronic Insomnia in Breast Cancer Survivors: Immune Mechanisms
ACTIVE NOT RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.